Literature DB >> 27411673

Immune suppressive properties of artemisinin family drugs.

Lifei Hou1, Haochu Huang2.   

Abstract

Artemisinin and its derivatives are the first-line antimalarial drugs, and have saved millions of lives across the globe, especially in developing world. The discovery of artemisinin by Youyou Tu was awarded the 2015 Nobel Prize in Physiology or Medicine. In addition to treating malaria, accumulating evidences suggest that artemisinin and its derivatives also possess potent anti-inflammatory and immunoregulatory properties. We recently showed that artesunate, an artemisinin analog, dramatically ameliorated autoimmune arthritis by selectively diminishing germinal center B cells. Herein, we review the immunosuppressive properties of artemisinin family drugs and the potential underlying mechanisms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artemisinin; Autoimmune diseases; Germinal center B cells; Immune regulation; Inflammation; T cells

Mesh:

Substances:

Year:  2016        PMID: 27411673      PMCID: PMC5035609          DOI: 10.1016/j.pharmthera.2016.07.002

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  57 in total

1.  The antimalarial drug artemisinin alkylates heme in infected mice.

Authors:  Anne Robert; Françoise Benoit-Vical; Catherine Claparols; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

2.  Effects of artesunate on immune function in mice.

Authors:  P Y Lin; Z M Feng; J Q Pan; D Zhang; L Y Xiao
Journal:  Zhongguo Yao Li Xue Bao       Date:  1995-09

Review 3.  Differential signaling by lymphocyte antigen receptors.

Authors:  J Alberola-Ila; S Takaki; J D Kerner; R M Perlmutter
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 4.  Current perspectives on the mechanism of action of artemisinins.

Authors:  Jacob Golenser; Judith H Waknine; Miriam Krugliak; Nicholas H Hunt; Georges E Grau
Journal:  Int J Parasitol       Date:  2006-09-12       Impact factor: 3.981

5.  Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  H Xu; Y He; X Yang; L Liang; Z Zhan; Y Ye; X Yang; F Lian; L Sun
Journal:  Rheumatology (Oxford)       Date:  2007-02-21       Impact factor: 7.580

6.  A trial of artemether or quinine in children with cerebral malaria.

Authors:  M B van Hensbroek; E Onyiorah; S Jaffar; G Schneider; A Palmer; J Frenkel; G Enwere; S Forck; A Nusmeijer; S Bennett; B Greenwood; D Kwiatkowski
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

7.  Identification of an antimalarial synthetic trioxolane drug development candidate.

Authors:  Jonathan L Vennerstrom; Sarah Arbe-Barnes; Reto Brun; Susan A Charman; Francis C K Chiu; Jacques Chollet; Yuxiang Dong; Arnulf Dorn; Daniel Hunziker; Hugues Matile; Kylie McIntosh; Maniyan Padmanilayam; Josefina Santo Tomas; Christian Scheurer; Bernard Scorneaux; Yuanqing Tang; Heinrich Urwyler; Sergio Wittlin; William N Charman
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

8.  Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.

Authors:  Bin Li; Rong Zhang; Jun Li; Lezhi Zhang; Guofu Ding; Ping Luo; Shengqi He; Yan Dong; Weiwei Jiang; Yongling Lu; Hongwei Cao; Jiang Zheng; Hong Zhou
Journal:  Int Immunopharmacol       Date:  2007-12-07       Impact factor: 4.932

9.  Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.

Authors:  Xin Li; Tian-Tian Li; Xiao-Hui Zhang; Li-Fei Hou; Xiao-Qian Yang; Feng-Hua Zhu; Wei Tang; Jian-Ping Zuo
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

10.  Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.

Authors:  Jigang Wang; Chong-Jing Zhang; Wan Ni Chia; Cheryl C Y Loh; Zhengjun Li; Yew Mun Lee; Yingke He; Li-Xia Yuan; Teck Kwang Lim; Min Liu; Chin Xia Liew; Yan Quan Lee; Jianbin Zhang; Nianci Lu; Chwee Teck Lim; Zi-Chun Hua; Bin Liu; Han-Ming Shen; Kevin S W Tan; Qingsong Lin
Journal:  Nat Commun       Date:  2015-12-22       Impact factor: 14.919

View more
  12 in total

1.  The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Pete T Mitchell; Аnarkul S Kishkentaeva; Zhanar R Shaimerdenova; Gayane A Atazhanova; Sergazy M Adekenov; Mark T Quinn
Journal:  Phytochemistry       Date:  2017-12-22       Impact factor: 4.072

Review 2.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

3.  Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer.

Authors:  Bingjun Bai; Fei Wu; Kangkang Ying; Yuzi Xu; Lina Shan; Yiming Lv; Xing Gao; Dengyong Xu; Jun Lu; Binbin Xie
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

4.  Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.

Authors:  Yuyuan Yao; Qinglong Guo; Yue Cao; Yangmin Qiu; Renxiang Tan; Zhou Yu; Yuxin Zhou; Na Lu
Journal:  J Exp Clin Cancer Res       Date:  2018-11-26

5.  Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity.

Authors:  Isabela P Ceravolo; Carlos L Zani; Flávio J B Figueiredo; Markus Kohlhoff; Antônio E G Santana; Antoniana U Krettli
Journal:  Malar J       Date:  2018-11-26       Impact factor: 2.979

6.  Anti-inflammatory effects of artesunate on atherosclerosis via miR-16-5p and TXNIP regulation of the NLRP3 inflammasome.

Authors:  Bo Li; Zheqi Zhang; Yili Fu
Journal:  Ann Transl Med       Date:  2021-10

Review 7.  Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.

Authors:  Yujun Tang; Jiajia Liu; Dingyi Zhang; Zhenghao Xu; Jinjun Ji; Chengping Wen
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

8.  Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.

Authors:  Guoming Li; Mei Yuan; Haihong Li; Changsheng Deng; Qi Wang; Yexiao Tang; Hongying Zhang; Weisheng Yu; Qin Xu; Yuanyuan Zou; Yueming Yuan; Jiawen Guo; Chunming Jin; Xiangdong Guan; Fengjie Xie; Jianping Song
Journal:  Int J Antimicrob Agents       Date:  2020-11-02       Impact factor: 5.283

Review 9.  Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs.

Authors:  Feifei Qiu; Junfeng Liu; Xiumei Mo; Huazhen Liu; Yuchao Chen; Zhenhua Dai
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

10.  Daily rhythms of both host and parasite affect antimalarial drug efficacy.

Authors:  Alíz T Y Owolabi; Sarah E Reece; Petra Schneider
Journal:  Evol Med Public Health       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.